News

Technology News

Cancer Therapeutics Reveals Second Drug Success

Thursday, July 05, 2012 5:01:00 AM PDT | VentureDeal
Melbourne, Australia  --  Cancer drug discovery company Cancer Therapeutics has announced the validation and performance of a new targeted drug.

Called CTx-294886, the drug has been tested in combination with Avastin in a preclinical model of breast cancer.

The drug is a small molecule inhibitor of Focal Adhesion Kinase and showed additional benefits versus the company's previous candidate, CTx-294945.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1